Linked Life Data

10494272

Source:http://linkedlifedata.com/resource/pubmed/id/10494272

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1999-10-4
pubmed:abstractText
CML is diagnosed most commonly in middle-aged patients following referral from primary care physicians. The majority of patients live at least 5 years when the disease is diagnosed and treated in the chronic phase. Survival is clearly prolonged by therapy, including interferon alfa-2b (used alone or in combination with other agents) and allogeneic bone marrow transplantation. With ongoing advances in allogeneic transplantation allowing matched related and unrelated donor transplants in older individuals with manageable complications, the need for timely identification of CML patients who are suitable candidates for this potentially curative intervention is critical.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0032-5481
pubmed:author
pubmed:issnType
Print
pubmed:volume
106
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
149-52, 157-9
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
1999
pubmed:articleTitle
Chronic myelogenous leukemia. Curable with early diagnosis and treatment.
pubmed:affiliation
Uniformed Services University of the Health Sciences, Division of Hematology/Oncology, National Naval Medical Center, Bethesda, USA.
pubmed:publicationType
Journal Article, Review